Cladribine is a medication used to treat hairy cell leukemia (HCL, leukemic
reticuloendotheliosis) and multiple sclerosis. Its chemical name is ...
(KLA-drih-bean). Trade name: Leustatin<sup>TM</sup> Other names: 2-CdA, 2-
Chlorodeoxyadenosine. Cladribine is the generic name for the trade name drug
Dec 16, 2015 ... Read about the cancer treatment drug cladribine, also called LITAK and Leustat,
including what it is, how it works and possible side effects.
Find a comprehensive guide to possible side effects when taking Leustatin (
Cladribine Injection For Intravenous Infusion Only) for Professionals, Patients,
Cladribine is a new purine nucleoside analogue with promising activity in low-
grade lymphoproliferative disorders, childhood acute myelogenous leukaemia ...
My father 60 years, was given 5-day Cladribine from March 30-April 3. His blood
counts almost after 2 months are around TLC- 2000, Hg- 8.9, Platelets- 52000, ...
Apr 28, 2015 ... The initiation of either cladribine or pentostatin may be associated with a
temporary worsening of the blood cell counts, so intervention should ...
Thirty-five patients received filgrastim and cladribine and were compared with
105 historic controls treated with cladribine alone. Cladribine was administered
Cladribine mechanism of action. 2-CdA enters the cell through an efficient
transport system. Cladribine is resistant to deamination by ADA. The high DCK to
Find out more about cladribine (Leustat ®, LITAK ®), a chemotherapy drug used
to treat hairy cell leukaemia and B-cell chronic lymphocytic leukaemia (CLL)